Measuring neurodevelopmental effects of polygenic risk for Alzheimer's disease via longitudinal study of brain and cognitive variables in periadolescent children

通过对青春期儿童大脑和认知变量的纵向研究来测量阿尔茨海默病多基因风险对神经发育的影响

• 批准号: 10395977
• 负责人: David E Warren
• 金额: $ 58.82万
• 依托单位: UNIVERSITY OF NEBRASKA MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-07-15 至 2024-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10395977
• 关键词: Address; Adolescent; Affect; Age; Aging; Alzheimer' s Disease; Alzheimer' s disease pathology; Alzheimer' s disease risk; Anterior; Biological Assay; Brain; Brain region; Child; Childhood; Clinical; Cognition; Cognitive; Complex; Coupled; Data; Data Set; Dementia; Development; Diagnosis; Disease; Early Intervention; Elderly; Enrollment; Environment; Face; Functional Magnetic Resonance Imaging; Genes; Genetic; Genetic Risk; Genomics; Goals; Hippocampus (Brain); Intervention; Knowledge; Late Onset Alzheimer Disease; Lead; Life; Longevity; Longitudinal Studies; Manuals; Measures; Memory; Memory Loss; Methods; Nerve Degeneration; Neurodegenerative Disorders; Neuropsychological Tests; Neuropsychology; Patients; Persons; Population; Prevalence; Property; Public Health; Research; Research Personnel; Research Project Grants; Rest; Risk; Risk Factors; Sampling; Structure; System; Techniques; Testing; Thick; Thinness; United States National Institutes of Health; Youth; abeta deposition; aged; care costs; cognitive ability; cognitive development; cognitive enhancement; cognitive neuroscience; cognitive testing; design; executive function; genome-wide; hippocampal atrophy; improved; indexing; individual variation; innovation; insight; longitudinal design; negative affect; nervous system disorder; neurodevelopment; neurodevelopmental effect; neuroimaging; novel; periadolescent; response; risk variant; sex; trend; whole genome

Project Summary/Abstract Alzheimer’s disease (AD) is a devastating, progressive neurological disorder that selectively degrades the cognition of many older adults — 6.1 million are living with AD in the US today and the estimated prevalence by 2050 is 12.7 million. Patients diagnosed with AD often live 8-10 years with the disease, but declines in memory and other cognitive abilities mean that patients face loss of independence and high costs of care (estimated to be $186 billion in 2018). Management of AD risk with targeted interventions is a needed part of our public health response, and genetic factors affecting AD risk will be essential to those efforts because they are present throughout the lifespan. Critically, it is possible that genetic AD risk factors may bias brain and cognitive development to increase vulnerability to AD later in life. A putative neurodevelopmental influence of genes on AD vulnerability would be consistent with 1) the predictive power of early cognitive ability for later AD risk, and 2) wide variability in how AD pathology (e.g., Aβ deposition) relates to AD symptomology (e.g., memory loss). Here, we hypothesize that genomic AD risk alters neurodevelopment of the brain systems most affected by AD in ways that increase AD vulnerability. If true, then properties of AD-affected brain structures and brain networks such as the hippocampus and functionally-coupled memory networks will vary with genetic AD risk even during youth. Measuring how genetic factors affect brain development will elucidate lifelong trends for AD risk while highlighting new opportunities for early intervention. The project lead is a new, early-stage investigator with a background in the cognitive neuroscience of memory and expertise in methods including neuroimaging and neuropsychology. In this study the investigators will apply these methods to the study of early polygenic effects on neurodevelopment that may affect the risk of late-onset neurodegenerative diseases including AD. Key preliminary data from large developmental datasets have provided important early support for this hypothesis, and the current proposal describes a new, tightly focused project designed to fill critical gaps in our existing knowledge. The Specific Aims are: 1) Measure effects of AD-related genes on developmental differences in AD-vulnerable brain regions; 2) Quantify how genes affect development of functional brain networks that are later vulnerable to AD; 3) Test developmental differences in AD-vulnerable cognitive abilities attributable to AD-related genes. For these Aims, the research team will develop a new dataset from a large sample (N=270) of healthy youths aged 9, 11, or 13 years by combining neuroimaging (brain structure/function), neuropsychological tests (cognition), and genomic assays (AD-related genes) in a longitudinal design. These data will improve the field’s understanding of the pressing clinical problem of AD from a developmental risk perspective. While addressing AD by studying children appears counterintuitive, this approach may be a crucial step toward addressing a looming public health catastrophe: some of today’s children are primed to become tomorrow’s dementia patients.

项目总结/文摘